THERAVECTYS
ID: 5290924A company developing T-cells vaccines for the treatment and prevention of infectious diseases, virally-induced cancers and cancers
2
Funding Rounds
$28.3m
Money raised
Recent Funding Rounds
Overview
A company developing T-cells vaccines for the treatment and prevention of infectious diseases, virally-induced cancers and cancers
- Website:
- Business model: B2B
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Pi**** Ch****** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company THERAVECTYS has raised a total of $28.32m in funding over 2 rounds.
Key Insights:
- THERAVECTYS Series D round: $18.91m
- THERAVECTYS Series C round: $9.41m
THERAVECTYS Series D round
$18.91m
THERAVECTYS Series C round
$9.41m
Industries
THERAVECTYS is active in the following industries: